-
Je něco špatně v tomto záznamu ?
High prevalence of hypovitaminosis D in postmenopausal women with type 2 Diabetes Mellitus
I. Raška, M. Rašková, V. Zikán, J. Škrha
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT11335
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Directory of Open Access Journals
od 2012
Medline Complete (EBSCOhost)
od 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2013
- MeSH
- absorpční fotometrie metody MeSH
- diabetes mellitus 2. typu * krev epidemiologie MeSH
- glykovaný hemoglobin analýza MeSH
- index tělesné hmotnosti MeSH
- lidé středního věku MeSH
- lidé MeSH
- nedostatek vitaminu D * krev diagnóza epidemiologie MeSH
- obezita * diagnóza epidemiologie MeSH
- postmenopauza metabolismus MeSH
- prevalence MeSH
- průřezové studie MeSH
- rizikové faktory MeSH
- senioři MeSH
- složení těla MeSH
- vitamin D analogy a deriváty krev MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
The link between vitamin D and type 2 diabetes mellitus (T2DM) is intensively studied. This study aims to define the serum concentration of 25-hydroxyvitamin D (25-OH D) and to investigate the relationship between 25-OH D status, glycated hemoglobin (HbA1c) and body composition in postmenopausal women with T2DM and in non-diabetic controls. In this cross-sectional study, 75 women with T2DM and 32 control subjects were selected. Serum 25-OH D, intact parathyroid hormone (PTH), calcium, fasting glucose and HbA1c, were measured. The mean 25-OH D level was 21.4±11.4 ng/ml (range 4.1-50.7 ng/ml) in diabetic women and 30.3±9.4 ng/ml (range 10.8-54.2 ng/ml) in control group (p<0.001). The prevalence of hypovitaminosis D (<30 ng/ml) was higher in vitamin D3 non-supplemented T2DM women (89% vs. 63% controls); the difference diminished in vitamin D3 (500-1000 IU per day) supplemented subgroups (45% diabetics vs. 42% controls). In T2DM women, 25-OH D levels were not associated to HbA1c, duration of diabetes, fasting glucose and PTH levels, however, 25-OH D levels negatively associated with body mass index (p=0.011), total body fat mass (p=0.005) and total body lean mass (p=0.004). The prevalence of hypovitaminosis D is higher in non-supplemented postmenopausal women with T2DM than in non-diabetic controls (89% vs. 63%). Obesity is a risk factor for vitamin D insufficiency in T2DM postmenopausal women. Further studies evaluating relationships between fat, muscle, bone and vitamin D metabolism in T2DM patients are warranted.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16019748
- 003
- CZ-PrNML
- 005
- 20190823130504.0
- 007
- ta
- 008
- 160721s2016 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.14712/23362936.2016.1 $2 doi
- 024 7_
- $a 10.14712/23362936.2016.1 $2 doi
- 035 __
- $a (PubMed)26995199
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Raška, Ivan $u 3rd Department of Medicine - Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic $7 xx0161018
- 245 10
- $a High prevalence of hypovitaminosis D in postmenopausal women with type 2 Diabetes Mellitus / $c I. Raška, M. Rašková, V. Zikán, J. Škrha
- 520 9_
- $a The link between vitamin D and type 2 diabetes mellitus (T2DM) is intensively studied. This study aims to define the serum concentration of 25-hydroxyvitamin D (25-OH D) and to investigate the relationship between 25-OH D status, glycated hemoglobin (HbA1c) and body composition in postmenopausal women with T2DM and in non-diabetic controls. In this cross-sectional study, 75 women with T2DM and 32 control subjects were selected. Serum 25-OH D, intact parathyroid hormone (PTH), calcium, fasting glucose and HbA1c, were measured. The mean 25-OH D level was 21.4±11.4 ng/ml (range 4.1-50.7 ng/ml) in diabetic women and 30.3±9.4 ng/ml (range 10.8-54.2 ng/ml) in control group (p<0.001). The prevalence of hypovitaminosis D (<30 ng/ml) was higher in vitamin D3 non-supplemented T2DM women (89% vs. 63% controls); the difference diminished in vitamin D3 (500-1000 IU per day) supplemented subgroups (45% diabetics vs. 42% controls). In T2DM women, 25-OH D levels were not associated to HbA1c, duration of diabetes, fasting glucose and PTH levels, however, 25-OH D levels negatively associated with body mass index (p=0.011), total body fat mass (p=0.005) and total body lean mass (p=0.004). The prevalence of hypovitaminosis D is higher in non-supplemented postmenopausal women with T2DM than in non-diabetic controls (89% vs. 63%). Obesity is a risk factor for vitamin D insufficiency in T2DM postmenopausal women. Further studies evaluating relationships between fat, muscle, bone and vitamin D metabolism in T2DM patients are warranted.
- 650 _2
- $a absorpční fotometrie $x metody $7 D015502
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a složení těla $7 D001823
- 650 _2
- $a index tělesné hmotnosti $7 D015992
- 650 _2
- $a průřezové studie $7 D003430
- 650 12
- $a diabetes mellitus 2. typu $x krev $x epidemiologie $7 D003924
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a glykovaný hemoglobin $x analýza $7 D006442
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a obezita $x diagnóza $x epidemiologie $7 D009765
- 650 _2
- $a postmenopauza $x metabolismus $7 D017698
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a vitamin D $x analogy a deriváty $x krev $7 D014807
- 650 12
- $a nedostatek vitaminu D $x krev $x diagnóza $x epidemiologie $7 D014808
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Rašková, Mária $u 3rd Department of Medicine - Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic $7 _AN072116
- 700 1_
- $a Zikán, Vít $u 3rd Department of Medicine - Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic $7 xx0074463
- 700 1_
- $a Škrha, Jan, $u 3rd Department of Medicine - Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic $d 1954- $7 jn99240001641
- 773 0_
- $w MED00013414 $t Prague medical report $x 1214-6994 $g Roč. 117, č. 1 (2016), s. 5-17
- 856 41
- $u https://pmr.lf1.cuni.cz/media/pdf/pmr_2016117010005.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 7 $c 1071 $y 4 $z 0
- 990 __
- $a 20160721 $b ABA008
- 991 __
- $a 20190823130718 $b ABA008
- 999 __
- $a ok $b bmc $g 1156642 $s 944276
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 117 $c 1 $d 5-17 $i 1214-6994 $m Prague Medical Report $n Prague Med. Rep. $x MED00013414
- GRA __
- $a NT11335 $p MZ0
- LZP __
- $b NLK118 $a Pubmed-20160721